AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Pharmacological Ascorbate Formulations Combined with EDTA Enhance Tumor Cell Killing

Detailed Technology Description

This is a new methodof improving the treatment of NSCLC and other cancers. It involvesadministering a novel combination of ascorbate and a metal chelating agent,such as ethylene diamine tetraacetic acid (EDTA), to increase tumor cellssensitivity to common cancer treatment options. When this combination isadministered to a patient, tumor cells have a much lower survival rate than whensubjected to traditional chemotherapy and radiation therapy methods. Increasing the efficacy of these methods couldlower the total cost and treatment time as well as improve patient outcome. Thistechnology could also reduce the need for risky surgical procedures by makingless invasive treatment options, like chemotherapy, more effective.

Country/Region

USA

For more information, please click Here